Hospital in Boston.
23. Christopher A. Rowland testified that on 10 January
1994, various physicians were requested to evaluate the Ultratome
XL and that on 8 February 1994, Dr. David Carr-Locke used the
Ultratome XL on a patient and completed the evaluation form (RR
026) .
24. In further support of its allegation that various
physicians received the Ultratome XL for their evaluation,
Rowland submits into evidence a letter dated January 10, 1994 to
Dr. Bohorfoush of Milwaukee, Wisconsin (Rowland Ex. 2032).
25. The letter refers to the Ultratome XL and describes the
device as improving cutting wire orientation and allowing the
user to inject contrast fluid in a separate injection lumen.
26. The letter states that the product is confidential and
for Dr. Bohorfoush's evaluation only.
27. In support of its assertion that Dr. Carr-Locke used
the three-lumen catheter in a patient on 8 February 1994, Rowland
submits into evidence exhibit 2033, which is entitled "Ultratome
XL Evaluation."
28. Inventors Vergano and Rowland testified that "Ultratome
XL" was the name given the three-lumen catheter made by the
Rowland inventors (RR 008, T 15; and 026).
9
Page: Previous 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 Next
Last modified: November 3, 2007